Also categorized in BoardMoves:
What Lies Ahead For Chesapeake As McClendon Exits?
x hide permanently

CytomX Therapeutics Appoints Elaine V. Jones, Ph.D., to Board of Directors

apnews.com

SOUTH SAN FRANCISCO, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody™ therapeutic technology platform, today announced that Elaine V. Jones, Ph.D., has joined the company’s board of directors effective May 1, 2019...

Mentions: Nasdaq CytomX technology